143 related articles for article (PubMed ID: 15558354)
1. Effects of prognostic factors and treatment on survival in advanced non-small cell lung cancer.
Cağlayan B; Fidan A; Salepçi B; Kiral N; Torun E; Salepçi T; Mayadağli A
Tuberk Toraks; 2004; 52(4):323-32. PubMed ID: 15558354
[TBL] [Abstract][Full Text] [Related]
2. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
3. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
4. [Survival and prognostic factors of non small cell lung cancer: analytic review of 211 cases].
Battikh MH; Ben Sayah MM; Joobeur S; Rouetbi N; Ben Salem K; Daami M; Maatallah A; Raham W; Farhat C; El Kamel A
Tunis Med; 2004 Sep; 82(9):843-8. PubMed ID: 15693478
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease.
Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M
Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors in patients with stage III and IV non-small cell lung cancer].
Song LH; Song XR; Liu MQ; Zhang XQ; Zheng L; Li XJ; Liu PX
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):345-8. PubMed ID: 15312344
[TBL] [Abstract][Full Text] [Related]
9. Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer.
Lavolé A; Chouaïd C; Baudrin L; Wislez M; Raguin G; Pialoux G; Girard PM; Milleron B; Cadranel J
Lung Cancer; 2009 Sep; 65(3):345-50. PubMed ID: 19135758
[TBL] [Abstract][Full Text] [Related]
10. Preoperative chemotherapy versus preoperative chemoradiotherapy for stage III (N2) non-small-cell lung cancer.
Higgins K; Chino JP; Marks LB; Ready N; D'Amico TA; Clough RW; Kelsey CR
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1462-7. PubMed ID: 19467798
[TBL] [Abstract][Full Text] [Related]
11. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection].
Wei WD; Wen ZS; Su XD; Lin P; Rong TH; Chen LK
Ai Zheng; 2007 Nov; 26(11):1231-6. PubMed ID: 17991324
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in resected stage I non-small cell lung cancer with a diameter of 3 cm or less: visceral pleural invasion did not influence overall and disease-free survival.
Hung JJ; Wang CY; Huang MH; Huang BS; Hsu WH; Wu YC
J Thorac Cardiovasc Surg; 2007 Sep; 134(3):638-43. PubMed ID: 17723811
[TBL] [Abstract][Full Text] [Related]
13. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
[TBL] [Abstract][Full Text] [Related]
14. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
[TBL] [Abstract][Full Text] [Related]
15. [In which stage we diagnose and how we treat lung cancer?].
Oztuna F; Ozlü T; Bülbül Y
Tuberk Toraks; 2003; 51(2):152-6. PubMed ID: 15143421
[TBL] [Abstract][Full Text] [Related]
16. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
[TBL] [Abstract][Full Text] [Related]
17. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
18. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
19. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]